Log in
Registration
Українська
English
Search for:
Home
Online Publication
Current Issue
Issue Archive
Authors
About
Information About the Journal
Focus and Scope
Indexing
For Authors
Submission Guidelines and Requirements
Peer Review
Article Processing Charges
Copyright and Licensing
Policies
Editorial Policy
Plagiarism Policy
Archiving Policy
Policy on the Use of Artificial Intelligence (AI) and AI-Supported Technologies
Open Access
Procedure for the Retraction of Published Articles
Ethical Issues
Publication Ethics
Procedure for Handling Complaints Regarding Ethical Breaches
Privacy Statement
International Standards and Principles of Operation
Organization of anticancer fight
Tumors of the chest cavity
Tumors of abdominal organs
Tumors of skin, soft tissues, bones
Breast tumor
Oncogynecology
Tumors of the head and neck
Oncurology
Oncohematology
Radiation diagnostics, radiation therapy
Experimental studies
Magazine online
All news
Rubric : Breast tumor
Clinical characteristics, treatment characteristics, and endpoints assessed in real-world clinical practice of talazoparib in patients with HER2-negative BRCA-associated breast cancer
Author:Huyvanyuk O.A. Т. 13, № 2 (50)
Assessment of overall survival obtained from the real-world study of using the combination of palbociclib with aromatase inhibitors as a first-line treatment of HR+/HER2− metastatic breast cancer
Т. 13, № 1 (49)
Surgery of inflammatory breast cancer
Authors: Smolanka I.I. Movchan O.V. Lyashenko A.O. Т. 13, № 1 (49)
The influence of amplification of ERBB2 is on the percent of relapse of inflammatory breast cancer after the combined treatment
Authors: Smolanka I. Movchan O.V. Liashenko А.А. Ivankova O.M.... Т. 12, № 1-2 (45-46)
Current state of hormone therapy in patients with metastatic breast cancer
Authors: Tarasenko T. Syvak L. Lyalkin S. Verovkina N.O.... Т. 12, № 1-2 (45-46)
Breast cancer: innovations for life. Part 2
Дата: 2022-09-01
Breast cancer: innovations for life. Part 1
Т. 12, № 1-2 (45-46)
Effect of chemokin polymorphisms on the efficacy of chemotherapy in patients with Her2/neu-negative breast cancer
Authors: Syvak L. Verovkina N.O. Lyalkin S. Tarasenko T.... Т. 11, № 3-4 (43-44)
Molecular mechanism of mammographic density formation of the breast tissue
Authors: Burlaka A.P. Ganusevich I.I. Motuziuk I.N. Sydorchuk O.I.... T. 10, № 1-2 (37-38)
Prognostic factors of metastatic luminal (Her2/neu-negative) breast cancer
Authors: Tarasenko T. Syvak L. Verevkina N. Lyalkin S.... T. 10, № 1-2 (37-38)
Nuclear transcription factor NF-kB content in the serum of patients with secondary edematous breast cancer
Authors: Bilyi O.M. Mitryaeva N.A. Krasnoselskyi M.V. Grebinyk L.V. T. 10, № 1-2 (37-38)
Implant-associated anaplastic large cell lymphoma (literature review)
Authors: Kolesnik O.P. Kechedzhyiev V.V. Levyk O.M. Kuzmenko V.A.... Дата: 2020-04-08
Neoadjuvant endocrine therapy in breast cancer premenopausal patients. Literature review and research results
Authors: Smolanka I. Ivankova O.N. Ignat M.V. Lygyrda O.F.... Т. 9, № 3 (35) 2019
Prognostic value of blood redox-state indicators in patients with breast cancer
Authors: Burlaka A.P. Sydorchuk O.I. Motuziuk I.N. Virko S.V.... Т. 9, № 3 (35) 2019
Role of TLR-2, TLR-4, TLR-9 gene polymorphism in prognosis of triple negative breast cancer
Authors: Lyalkin S. Sivak L.A. Khranovska N.M. Verovkina N.O. Т. 9, № 2 (34) 2019
1
2
3
4
5
»